OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY

被引：0
作者：
Schmalzing, M. [1 ]
Askari, A. [2 ]
Sheeran, T. [3 ]
Jathanakodi, S. [4 ]
Both, C. [4 ]
Kellner, H. [5 ]
机构：
[1] Wuerzburg, Univ Hosp, Dept Internal Med 2, Rheumatol Clin Immunol, Wurzburg, Germany
[2] Robert Jones & Agnes Hunt Orthoped Hosp NHS Fdn T, Rheumatol, Oswestry, Shrops, England
[3] Univ Wolverhampton, New Cross & Cannock Chase Hosp, Dept Rheumatol, Wolverhampton, England
[4] Sandoz Hexal AG, Rheumatol, Holzkirchen, Germany
[5] Hosp Neuwittelsbach, Ctr Rheumatol & Gastroenterol, Munich, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Spondyloarthritis; Patient reported outcomes;
D O I：
10.1136/annrheumdis-2023-eular.442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0419
引用
收藏
页码：1397 / 1397
页数：1
相关论文
共 27 条
  • [21] Treatment patterns and clinical outcomes in patients with rheumatoid arthritis initiating etanercept, adalimumab, or Janus kinase inhibitor as first-line therapy: results from the real-world CorEvitas RA Registry
    Dimitrios A. Pappas
    Jacqueline O’Brien
    Lin Guo
    Ying Shan
    Joshua F. Baker
    Gregory Kricorian
    Scott Stryker
    David H. Collier
    Arthritis Research & Therapy, 25
  • [22] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study (vol 38, pg 1413, 2019)
    Alten, Rieke
    Mariette, Xavier
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Galeazzi, Mauro
    Navarro, Federico
    Chartier, Melanie
    Heitzmann, Julia
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1535 - 1535
  • [23] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Gossec, Laure
    Siebert, Stefan
    Bergmans, Paul
    de Vlam, Kurt
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Korotaeva, Tatiana V.
    Lavie, Frederic
    Noel, Wim
    Nurmohamed, Michael T.
    Sfikakis, Petros P.
    Sharaf, Mohamed
    Theander, Elke
    Smolen, Josef S.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [24] Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
    Laure Gossec
    Stefan Siebert
    Paul Bergmans
    Kurt de Vlam
    Elisa Gremese
    Beatríz Joven-Ibáñez
    Tatiana V. Korotaeva
    Frederic Lavie
    Wim Noël
    Michael T. Nurmohamed
    Petros P. Sfikakis
    Mohamed Sharaf
    Elke Theander
    Josef S. Smolen
    Arthritis Research & Therapy, 25
  • [25] Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study
    Andrew Östör
    Eugen Feist
    Prodromos Sidiropoulos
    Jérôme Avouac
    Martin Rebella
    Rajaie Namas
    Erin McDearmon-Blondell
    Tianming Gao
    Ivan Lagunes-Galindo
    Sander Strengholt
    Devy Zisman
    Suzan Attar
    Arthritis Research & Therapy, 27 (1)
  • [26] Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study
    Momohara, Shigeki
    Hashimoto, Jun
    Tsuboi, Hideki
    Miyahara, Hisaaki
    Nakagawa, Natsuko
    Kaneko, Atsushi
    Kondo, Naoki
    Matsuno, Hiroaki
    Wada, Takahiko
    Nonaka, Tohgo
    Kanbe, Katsuaki
    Takagi, Haruki
    Murasawa, Akira
    Matsubara, Tsukasa
    Suguro, Toru
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 440 - 449
  • [27] Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis
    Yamanaka, Hisashi
    Tanaka, Yoshiya
    Hibino, Toshihiko
    Unmesh, Gopalakrishnan
    Shah, Chirag
    Bakhle, Dhananjay
    Stefanidis, Dimitris
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) : 108 - 115
123